Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biologically Regulated Marrow Stimulation by Blocking Fibrosis to Improve Cartilage Repair: A Randomized Double-Blind, Placebo-Controlled Study

NCT04212650 is registered in ClinicalTrials.gov with Steadman Philippon Research Institute as lead sponsor.

NCT NCT04212650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04212650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biologically Regulated Marrow Stimulation by Blocking Fibrosis to Improve Cartilage Repair: A Randomized Double-Blind, Placebo-Controlled Study
Lead sponsor
Steadman Philippon Research Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
August 7, 2020
Completion date
December 4, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage damage, fibrosis, hip impingement syndrome, hip osteoarthritis